| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 46.8569 | 36 |
| GSM780708 | Untreated after 4 days (C2_1) | 44.3396 | 24 |
| GSM780709 | Untreated after 4 days (C3_1) | 52.8065 | 56 |
| GSM780719 | Untreated after 4 days (C1_2) | 48.446 | 43 |
| GSM780720 | Untreated after 4 days (C2_2) | 47.4071 | 39 |
| GSM780721 | Untreated after 4 days (C3_2) | 49.5013 | 47 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 44.2123 | 23 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 41.2872 | 10 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.3006 | 38 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 50.2999 | 49 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 49.6786 | 47 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 48.6311 | 44 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 43.9569 | 22 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 41.0337 | 10 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 53.1735 | 56 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 49.6275 | 47 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 51.7738 | 53 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 47.2372 | 38 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 48.5695 | 43 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 45.0525 | 27 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 43.7085 | 21 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.9607 | 41 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 43.5574 | 20 |